chr1-43441565-G-A

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_001365999.1(SZT2):​c.7573G>A​(p.Val2525Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,614,176 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V2525G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0065 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 15 hom. )

Consequence

SZT2
NM_001365999.1 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.31
Variant links:
Genes affected
SZT2 (HGNC:29040): (SZT2 subunit of KICSTOR complex) The protein encoded by this gene is expressed in the brain, predominantly in the parietal and frontal cortex as well as in dorsal root ganglia. It is localized to the peroxisome, and is implicated in resistance to oxidative stress. It likely functions by increasing superoxide dismutase (SOD) activity, but itself has no direct SOD activity. Studies in mice show that this gene confers low seizure threshold, and may also enhance epileptogenesis. [provided by RefSeq, Jun 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SZT2. . Gene score misZ 2.5968 (greater than the threshold 3.09). Trascript score misZ 4.0086 (greater than threshold 3.09). GenCC has associacion of gene with undetermined early-onset epileptic encephalopathy, developmental and epileptic encephalopathy, 18, developmental and epileptic encephalopathy.
BP4
Computational evidence support a benign effect (MetaRNN=0.0036810935).
BP6
Variant 1-43441565-G-A is Benign according to our data. Variant chr1-43441565-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 416970.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-43441565-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00652 (993/152290) while in subpopulation AFR AF= 0.0226 (941/41564). AF 95% confidence interval is 0.0214. There are 9 homozygotes in gnomad4. There are 487 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SZT2NM_001365999.1 linkuse as main transcriptc.7573G>A p.Val2525Ile missense_variant 54/72 ENST00000634258.3
SZT2NM_015284.4 linkuse as main transcriptc.7402G>A p.Val2468Ile missense_variant 53/71

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SZT2ENST00000634258.3 linkuse as main transcriptc.7573G>A p.Val2525Ile missense_variant 54/725 NM_001365999.1 P1Q5T011-1
SZT2ENST00000562955.2 linkuse as main transcriptc.7402G>A p.Val2468Ile missense_variant 53/715 Q5T011-5
SZT2ENST00000648058.1 linkuse as main transcriptn.4027G>A non_coding_transcript_exon_variant 22/40
SZT2ENST00000649403.1 linkuse as main transcriptn.2323G>A non_coding_transcript_exon_variant 19/37

Frequencies

GnomAD3 genomes
AF:
0.00652
AC:
992
AN:
152172
Hom.:
9
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0227
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00576
GnomAD3 exomes
AF:
0.00173
AC:
434
AN:
251412
Hom.:
5
AF XY:
0.00132
AC XY:
179
AN XY:
135866
show subpopulations
Gnomad AFR exome
AF:
0.0238
Gnomad AMR exome
AF:
0.000925
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000634
AC:
927
AN:
1461886
Hom.:
15
Cov.:
52
AF XY:
0.000550
AC XY:
400
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0225
Gnomad4 AMR exome
AF:
0.000872
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000306
Gnomad4 OTH exome
AF:
0.00151
GnomAD4 genome
AF:
0.00652
AC:
993
AN:
152290
Hom.:
9
Cov.:
32
AF XY:
0.00654
AC XY:
487
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.0226
Gnomad4 AMR
AF:
0.00209
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00570
Alfa
AF:
0.00125
Hom.:
4
Bravo
AF:
0.00753
ESP6500AA
AF:
0.0268
AC:
118
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00218
AC:
265
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxOct 08, 2018- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsAug 31, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 27, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsSep 14, 2018- -
Developmental and epileptic encephalopathy, 18 Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabApr 11, 2023- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 23, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
2.1
DANN
Benign
0.87
DEOGEN2
Benign
0.064
T;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.095
N
LIST_S2
Benign
0.57
T;T
MetaRNN
Benign
0.0037
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.1
L;.
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.36
.;N
Sift
Benign
1.0
.;T
Sift4G
Benign
0.068
T;T
Polyphen
0.0010
.;B
Vest4
0.14
MVP
0.072
MPC
0.30
ClinPred
0.0059
T
GERP RS
0.33
Varity_R
0.013
gMVP
0.27

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs139486476; hg19: chr1-43907236; API